s-silkworm oligopeptide-1 sp은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

s-silkworm oligopeptide-1 sp은 임신 중 안전한가요?

No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.

s-silkworm oligopeptide-1 sp은 모유 수유 중 안전한가요?

No evidence of breastmilk transfer or systemic reproductive/breastfeeding-specific toxicity for silk-derived oligopeptides; peptides applied topically generally show low systemic bioavailability, so risk to nursing infants is not indicated. Sources: PubMed on topical peptide absorption, CosIng/PubChem entries; no regulatory flags (ECHA Annex VI/CIR).

s-silkworm oligopeptide-1 sp은 아기 피부에 안전한가요?

Hazard and mechanism remain 0 (no data indicating reproductive/developmental toxicity). Exposure increased by one level for infants because immature skin barrier and higher surface-area-to-weight can increase systemic uptake; while adult dermal absorption is expected negligible, baby exposure is considered low but measurable (e=1). No infant-specific toxicity data found. Sources: general dermal absorption principles in peer-reviewed literature; regulatory databases (CosIng, PubChem); absence of adverse classifications (ECHA Annex VI/CIR).

VeriMom은 s-silkworm oligopeptide-1 sp을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 s-silkworm oligopeptide-1 sp을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 s-silkworm oligopeptide-1 sp 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.